Does mindfulness meditation help depression during COVID-19?
Yes. In a systematic review and meta-analysis of randomized controlled trials conducted during the COVID-19 pandemic, mindfulness meditation reduced depressive symptoms in people with depression compared with comparison groups (SMD = -1.14; 95% CI -1.45 to -0.83; p < 0.001). This is pooled evidence from trials, not a single new study.
Mindfulness meditation is taught as non-judgmental awareness of present-moment experience, and it is used clinically to reduce rumination, support emotional regulation, and give people a structured coping practice during periods of isolation and uncertainty.
What the data show:
- Effect on depressive symptoms: SMD = -1.14 (95% CI -1.45 to -0.83), favoring mindfulness meditation over comparison groups
- Statistical significance: p < 0.001
- Study scope: 26 randomized controlled trials in individuals with depression, conducted during the COVID-19 pandemic
- Evidence base: Four databases searched in November 2023 (PubMed, Embase, Web of Science, Scopus)
- Analysis method: Random-effects model with standardized mean differences and 95% confidence intervals, run in Review Manager 5.4
A systematic review and meta-analysis published in Scientific Reports examined randomized controlled trials of mindfulness meditation carried out during the COVID-19 pandemic and found a positive effect on depressive symptoms in individuals with depression.
Dr. Kumar’s Take
This meta-analysis is worth attention because it addresses a real-world crisis, the rise in depression during COVID-19. Mindfulness meditation is accessible in a way most treatments are not: when people could not reach a clinic or were isolated at home, meditation could still be practiced without equipment or a prescription. The pandemic combined social isolation, uncertainty, disrupted routines, and chronic stress, and mindfulness practice targets several of those directly through reduced rumination, better emotional regulation, and a repeatable daily structure. I read the pooled result as supportive rather than definitive: it is an average across trials with different populations and different comparison conditions, and an average effect tells me the direction of benefit, not what any one patient in front of me will get.
Study Snapshot
This systematic review and meta-analysis examined mindfulness meditation interventions for depressive symptoms in individuals with depression during the COVID-19 pandemic. The researchers analyzed randomized controlled trials only, and 26 such trials were included in the systematic review. Four databases were searched in November 2023 (PubMed, Embase, Web of Science, and Scopus) using search terms covering meditation, mindfulness, depression, and depressive symptoms. The aim was to assess evidence-based practice for reducing depressive symptoms during the pandemic, at a time when roughly 280 million people worldwide were living with depression and the condition ranked third in the global burden of disease.
Results in Real Numbers
The systematic review included 26 randomized controlled trials conducted during the COVID-19 pandemic. Pooling continuous outcomes with a random-effects model and standardized mean differences, the meta-analysis found a significant effect of mindfulness meditation interventions on depressive symptoms compared with comparison groups: SMD = -1.14, 95% confidence interval -1.45 to -0.83, p < 0.001. The negative sign indicates lower depressive symptom scores in the meditation groups.
The confidence interval sits entirely below zero, so the pooled benefit was consistent in direction across the range of plausible values. The analysis was performed in Review Manager 5.4 (Cochrane Collaboration). The authors concluded that the findings suggest a positive effect of mindfulness meditation on depressive symptoms in individuals with depression during the COVID-19 pandemic.
Who Benefits Most
The trials enrolled individuals with depression during the COVID-19 pandemic, so that is the group the pooled result speaks to most directly. People whose depressive symptoms were driven or worsened by pandemic conditions such as social isolation, health anxiety, or disrupted routines fall squarely within that population.
Mindfulness meditation is also a practical option for people who want a self-directed tool they can use at home, particularly when in-person care is hard to reach. That is a judgement about accessibility rather than a subgroup result from this analysis.
Safety, Limits, and Caveats
This is pooled evidence, not a single trial. A pooled benefit does not tell you which specific mindfulness program to choose or how any individual will respond.
The review was restricted to trials conducted during the COVID-19 pandemic, so the findings are anchored to that period and those conditions. Meditation is not a substitute for professional assessment and treatment of depression, particularly for severe or treatment-resistant illness, and anyone whose symptoms are worsening should be evaluated by a clinician.
Practical Takeaways
- Treat mindfulness meditation as an evidence-supported adjunct for depressive symptoms, based on pooled randomized trial data
- Use mindfulness alongside, not instead of, professional care when depression is moderate or severe
- Keep meditation as one part of a broader plan that includes sleep, activity, and clinical follow-up
- If symptoms worsen or do not improve, escalate to formal treatment rather than continuing meditation alone
What This Means for Mental Health Crisis
Pooled randomized trial evidence from the pandemic period supports mindfulness meditation as an intervention that reduces depressive symptoms in people with depression. That matters for planning, because meditation programs are inexpensive to scale and can be delivered when in-person services are strained.
The authors framed their question around the need for evidence-based practice during an unprecedented period, and the result gives public health planners a defensible option to include in mental health responses rather than a replacement for clinical services.
Related Studies and Research
Episode 31: Depression Explained, The Biology Behind the Darkness
Episode 32: Depression Recovery Roadmap: A Step-by-Step, Evidence-Based Plan
Mindfulness-Based Cognitive Therapy for Depression Prevention
FAQs
Can mindfulness meditation replace professional treatment for pandemic-related depression?
No. The trials tested meditation as an intervention for depressive symptoms, and I would use it as part of comprehensive mental health care rather than as a replacement for professional treatment.
How large was the effect on depressive symptoms?
The pooled standardized mean difference was -1.14 (95% CI -1.45 to -0.83, p < 0.001), favoring mindfulness meditation over comparison groups.
What kind of studies did this analysis include?
Only randomized controlled trials, all conducted during the COVID-19 pandemic in individuals with depression, identified through four databases searched in November 2023.
Bottom Line
In a systematic review and meta-analysis of randomized controlled trials run during the COVID-19 pandemic, mindfulness meditation significantly reduced depressive symptoms in people with depression compared with comparison groups (SMD = -1.14; 95% CI -1.45 to -0.83; p < 0.001), supporting it as a useful part of care during crisis conditions.
